ArticleEuropean heart journal open2026
Circulating biomarkers and mortality in atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke study.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Examination of biomarkers associated with mortality among people with atrial fibrillation (AF) may help identify possible preventive interventions in this high-risk population. We aimed to study associations of circulating biomarkers with all-cause and cause-specific mortality in persons with AF in the US national biracial REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Methods and results: REGARDS enrolled 30 239 Black and White adults aged ≥45 in 2003-07. Candidate biomarkers were measured in all participants with baseline AF and no prior stroke ( Conclusion: Several biomarkers were associated with all-cause and cardiovascular mortality in AF, suggesting multiple domains of clinical relevance that support interventions to reduce mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.